HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status

Background. Although specific human immunodeficiency virus type 1 (HIV-1) drug resistance mutations are well studied, little is known about cumulative amino acid changes, or how regimen and participant characteristics influence these changes. Methods. In the AIDS Clinical Trials Group randomized stu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mollan, Katie, Daar, Eric S., Sax, Paul E., Balamane, Maya, Collier, Ann C., Fischl, Margaret A., Lalama, Christina M., Bosch, Ronald J., Tierney, Camlin, Katzenstein, David
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2012
Sujets:
Major Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3502379/
https://ncbi.nlm.nih.gov/pubmed/23148287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis613
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires